Lithium Supplies Seen Rising, Weighing on Prices

Lithium supplies are expected to rise and potentially push down prices of the battery metal, Morgan Stanley analysts say. Australia’s spodumene shipments should start to improve in the coming months and African shipments should also recover following the end of the wet season, say the MS analysts. China is likely to record another year of strong production growth after easing environmental restrictions, and Chile’s exports are touching all-time highs, they add. “While the lithium price has held up well year-to-date, a loosening [supply-demand] balance from here brings downside risks,” say the analysts. “The China lithium carbonate price is currently trading close to our base case of $13,500/ton but we see room for it to fall below this, with the price already starting to roll over recently.”

Lithium Supplies Seen Rising, Weighing on Prices Read Post »

Oracle Trades One-Time License Revenue for Large Cloud Contracts

Oracle’s results are getting a boost from longer recurring contracts. CEO Safra Catz says on a call with analysts that the company is trading one-time, non-recurring license revenue for larger “strategic customer commitments.” Those deals, which have surged because of strong demand for AI products and training large language models, stretch multiple years, she said, and are expected to lead to accelerating revenue growth. Oracle announces two big wins, one with Google Cloud and one with Microsoft and OpenAI, and those large contracts appear to be showing up in the company’s remaining performance obligations, a proxy for backlog. RPO was up 44% year-on-year in 4Q. Shares rise 9.7% post-market.

Oracle Trades One-Time License Revenue for Large Cloud Contracts Read Post »

Oracle CEO: Long-Term Targets May Prove Too Conservative

Oracle’s AI momentum is making longer-term financial targets look meager. CEO Safra Catz says on a call with analysts that she is still “firmly committed” to FY26 targets for revenue, margins and earnings. “However, given our strong bookings results, I believe some of these goals might prove to be too conservative given our momentum,” she says. And Oracle seems to be prepared to spend big to keep momentum going: Catz says capital expenditures this fiscal year will likely be double that of the previous fiscal year. Shares rise 8.8% to $134.75 after-hours.

Oracle CEO: Long-Term Targets May Prove Too Conservative Read Post »

Oracle Wants A Cloud Deal With AWS

After arrangements to connect its cloud customers with Google and Microsoft, Oracle says that a deal with Amazon Web Services could be next. CTO Larry Ellison says on a call with analysts that the company believes all clouds should be interconnected, making it easier for customers who use multiple cloud services to use them all at once. Oracle already has connections with Microsoft’s Azure and on Tuesday announces a new partnership with Google. Ellison says the company would “love to do the same thing with AWS,” adding that he is optimistic that interconnection will become the status quo. Shares rise 9.3% to $135.35 after-hours.

Oracle Wants A Cloud Deal With AWS Read Post »

CFRA Maintains Hold Recommendation On Shares Of Oracle Corporation

We up our 12-month target to $150 from $142, on a P/E of 22x our CY25 EPS estimate of $6.80, above historical/below peers. We keep our FY25 (May) EPS at $6.29 and start FY26 at $7.08. ORCL posts May-Q EPS of $1.63 vs. $1.67, missing the $1.65 consensus. Sales rose 3%, as 20% growth from cloud services was largely offset by declines in licenses, hardware, and services. Infrastructure-as-a-Service (IaaS) grew +42%, now 14% of sales (run rate doubled in the last seven Qs) and is benefiting from large-scale deals (+30 AI sales contracts for over $12.5B; Open AI deal to train ChatGPT adds credibility). RPO rose an impressive 44% to $98B (+29% in Feb-Q), driving its backlog and will allow ORCL to grow +10% in FY25. Applications decelerated to 10% but Cerner headwinds to ease. The Google Cloud partnership is poised to aid database services revenue, which could add another

CFRA Maintains Hold Recommendation On Shares Of Oracle Corporation Read Post »

Oracle Touts AI Deals Amid 4Q Earnings Miss

Oracle is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The cloud-software provider reported fourth-quarter results that fell short of Wall Street expectations, but it also touted major artificial-intelligence contracts and said it expects demand to keep accelerating. Oracle shares rise nearly 10% in premarket trading. Dow Jones & Co. owns Factiva.

Oracle Touts AI Deals Amid 4Q Earnings Miss Read Post »

Oracle’s Solid Cloud Performance Fuels Growth in Q4 Backlog, BofA Says

Oracle’s (ORCL) solid growth driven by strong cloud performance, resulting in an increase in quarter-over-quarter remaining performance obligations and backlog in Q4, BofA Securities said in a note. “Oracle delivered solid Q4 results, with cloud strength driving incremental backlog/RPO of $18 billion, driven by strength in multi year hosting deals,” BofA said, adding that total cloud subscription growth of 20% was below guidance, but Oracle Cloud Infrastructure’s 43% growth remained solid, though slightly decelerated. “However, with outsized growth coming from the hardware intensive OCI business, the economics in Oracle’s business are likely to come down over time,” BofA said. Oracle plans to double its capital expenditure in 2025, representing 25% of revenue, up from 13% in 2024. Despite reaffirming 2026 targets, concerns persist regarding margin erosion and low research and development investment. BofA maintained its neutral rating while raising its price target to $155 from $144 to reflect improving topline

Oracle’s Solid Cloud Performance Fuels Growth in Q4 Backlog, BofA Says Read Post »

Oracle Rides Strong On The AI Wave, Despite Q4 Revenue Miss: 8 Analysts’ Insights

Oracle Corp (NYSE:ORCL) shares were climbing on Wednesday after the company reported its quarterly results. The results came amid an exciting earnings season. Here are some key analyst takeaways. Piper Sandler On Oracle Analyst Brent Bracelin maintained an Overweight rating, while raising the price target from $140 to $150. Oracle’s reported quarterly revenue miss of $242 million “takes a back seat to leading indicators like RPO metrics,” given its backlog strength, especially the new contract signings of $32 billion in just six months, Bracelin said in a note. RPO growth accelerated from the previous quarter’s 29% to 44% year-on-year to $98 billion, “driven by robust new AI contract signings,” the analyst stated, while adding that the company’s cRPO growth remained at 15% for the second consecutive quarter. “Non-GAAP operating margin improved q/q to 46.7% from 43.6%,” he further wrote. Stifel On Oracle Analyst Brad Reback reiterated a Hold rating while

Oracle Rides Strong On The AI Wave, Despite Q4 Revenue Miss: 8 Analysts’ Insights Read Post »

Oracle’s Strong Cloud Bookings Results Support Future Growth, Oppenheimer Says

Oracle’s (ORCL) “strong finish” to its fiscal 2024, with cloud bookings results exceeding investor expectations, supports future growth, Oppenheimer said in a note to clients Wednesday. The database management company reported late Tuesday Q4 remaining performance obligation, or RPO, rose 44% year over year to $98 billion, while Infrastructure as a Service, or IaaS grew by 42% year over year. Oppenheimer said it sees “Oracle as a long-term beneficiary of the software industry secular trends,” which include digital transformation, cloud computing and generative artificial intelligence. These trends are expected to drive “revenue growth and operating leverage for the company,” it added. Oracle, however, reported earnings per share and revenue that missed analysts’ expectations, likely raising concerns that the company’s fiscal 2025 guidance is “aggressive,” Oppenheimer said. The company guided its fiscal 2025 revenue to grow double digits and the growth rate to increase each quarter, as well as its IaaS

Oracle’s Strong Cloud Bookings Results Support Future Growth, Oppenheimer Says Read Post »

CFRA Maintains Buy Opinion On Shares Of Broadcom Inc.

We up our 12-month target to $1,850 from $1,600 on a P/E of 30x our CY 25 EPS view, above historical rising AI and software exposure. We keep our FY 24 (Oct.) EPS at $49.16 and raise FY 25 to $60.00 from $56.90. AVGO posts Apr-Q EPS of $10.96 vs. $10.32, beating the $10.84 consensus. Sales rose 43% (+12% ex. VMware), with Infrastructure Software +175% and Semiconductor Solutions +6%. AI sales grew 280% ($3.1B in Apr-Q; +$11B now seen in FY 24) and is driving upside, while non-AI semiconductor sales appear to have bottomed out. Networking growth of 44% (53% of semi sales) is being led by momentum for its Ethernet switches (Tomahawk 5/Jericho 3) and higher customer silicon revenue. We think VMware integration is progressing ahead of schedule given sharply lower spending (seen at $1.3B exiting Q4 from $1.6B in Apr-Q/$2.3B in late ’23), streamlining SKUs (from over 8,000

CFRA Maintains Buy Opinion On Shares Of Broadcom Inc. Read Post »

Boeing Jet Deliveries Limp Along, With China on Hold

Boeing had another month of muted jet deliveries as it grappled with supplier issues, increased regularity scrutiny and its own efforts to improve quality. Deliveries to China also are on hold amid a Chinese review of the batteries that power the planes’ cockpit data recorder. The airplane maker delivered 24 jets in May, 19 of which were 737 MAXs. Boeing had hoped to be rolling out close to 40 planes a month by now before fallout from the Alaska Airlines door-plug blowout in January slowed production. Boeing booked four orders in the month, all for its 787-10 wide-body jet

Boeing Jet Deliveries Limp Along, With China on Hold Read Post »

Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

Moderna, Inc. (NASDAQ:MRNA) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 1:20 PM ET Company Participants Stephen Hoge – President Conference Call Participants Salveen Richter – Goldman Sachs Salveen Richter Great. Good afternoon, everyone. Thank you so much for joining us. Really pleased to have Stephen Hoge, President of Moderna with us this morning. Stephen Hoge Thanks for having us. Question-and-Answer Session Q – Salveen Richter After having just announced some news today on the COVID-flu combo, perhaps before we get into that, some big-picture questions, Moderna has over 40 programs in development. And in the context of R&D spend management, what is your strategy for pipeline prioritization? Stephen Hoge Great question. So, well, thank you, first of all. It’s really exciting to be here, the first time in Miami with you too. So, first on the question of prioritization, as you know well, because you’ve followed us

Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Read Post »

Scroll to Top